Drugs / SPARC1210
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02136927 | Aug 2014 → Apr 2016 | breast cancer | Sun Pharma Advanced Research Company Limited | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPARC1210 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02136927 ↗ |
| Route | Intravenous | “Intravenous administration of SPARC1210” NCT02136927 ↗ |